FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384664709> ?p ?o ?g. }

• W4384664709 endingPage "560" @default.
• W4384664709 startingPage "553" @default.
• W4384664709 abstract "N-acetyl cysteine (NAC) is a potent antioxidant that modulates glutamatergic signalling which is thought to play a role in alcohol use disorder (AUD). There have been no clinical trials investigating NAC for AUD. We aimed to conduct a 28 day double-blind, placebo-controlled (PL) randomized trial of NAC in the treatment of AUD (NCT03879759). A total of 42 participants with AUD (56% alcohol-related liver disease) were randomized to receive placebo or NAC 2400 mg/day. Feasibility outcomes included treatment retention and adverse events. Primary clinical outcomes included alcohol consumption (heavy drinking days, standard drinks per drinking day). Secondary clinical outcome measures included craving, liver tests, and psychological outcomes. There were no significant differences in overall retention between treatment groups (χ2(1) = 0.14, P = 0.71: 86% vs 76% for placebo and NAC, respectively). The most commonly reported adverse event in NAC-treated individuals included headache (14%). For standard drinks per drinking day, there was a significant overall effect of time (F = 9.18, P < 0.001), no significant effect of treatment (F = 0.75, P = 0.79), and a significant time x treatment (NAC vs PL) effect (F = 2.73, P < 0.05). For number of heavy drinks per day, there was a significant overall effect of time (F = 3.16, P < 0.05) but no significant effect of treatment or time x treatment (P = 0.17). There were no significant NAC vs PL effects on secondary clinical outcome measures. In the first trial of NAC for the management of AUD, NAC appears to be feasible and safe. Although there was a significant effect of NAC vs placebo on some alcohol measures such as drinks per drinking day, there does appear to be a variable pattern of effect across time suggesting that a larger trial incorporating a longer treatment duration is now required to determine efficacy." @default.
• W4384664709 created "2023-07-20" @default.
• W4384664709 creator A5004395530 @default.
• W4384664709 creator A5011903525 @default.
• W4384664709 creator A5026168174 @default.
• W4384664709 creator A5032417354 @default.
• W4384664709 creator A5064849327 @default.
• W4384664709 creator A5066732257 @default.
• W4384664709 creator A5071884095 @default.
• W4384664709 creator A5084256816 @default.
• W4384664709 date "2023-07-18" @default.
• W4384664709 modified "2023-09-25" @default.
• W4384664709 title "N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebo-controlled trial" @default.
• W4384664709 cites W1498046084 @default.
• W4384664709 cites W1981368166 @default.
• W4384664709 cites W1981444301 @default.
• W4384664709 cites W2022169778 @default.
• W4384664709 cites W2029809671 @default.
• W4384664709 cites W2078357006 @default.
• W4384664709 cites W2079345780 @default.
• W4384664709 cites W2082850379 @default.
• W4384664709 cites W2101199513 @default.
• W4384664709 cites W2110117912 @default.
• W4384664709 cites W2123282949 @default.
• W4384664709 cites W2124273275 @default.
• W4384664709 cites W2158454106 @default.
• W4384664709 cites W2305927117 @default.
• W4384664709 cites W2312923997 @default.
• W4384664709 cites W2602811693 @default.
• W4384664709 cites W2603343844 @default.
• W4384664709 cites W2617253378 @default.
• W4384664709 cites W2774637825 @default.
• W4384664709 cites W2794062090 @default.
• W4384664709 cites W2800700023 @default.
• W4384664709 cites W2802163639 @default.
• W4384664709 cites W2884240197 @default.
• W4384664709 cites W2884279853 @default.
• W4384664709 cites W2900039414 @default.
• W4384664709 cites W2986162715 @default.
• W4384664709 cites W3047867407 @default.
• W4384664709 cites W3083218423 @default.
• W4384664709 cites W3131433731 @default.
• W4384664709 cites W3163254953 @default.
• W4384664709 cites W3175471267 @default.
• W4384664709 cites W3202397096 @default.
• W4384664709 cites W4212862987 @default.
• W4384664709 cites W4232615320 @default.
• W4384664709 cites W4236805817 @default.
• W4384664709 cites W4323309604 @default.
• W4384664709 cites W4376849345 @default.
• W4384664709 doi "https://doi.org/10.1093/alcalc/agad044" @default.
• W4384664709 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37465907" @default.
• W4384664709 hasPublicationYear "2023" @default.
• W4384664709 type Work @default.
• W4384664709 citedByCount "0" @default.
• W4384664709 crossrefType "journal-article" @default.
• W4384664709 hasAuthorship W4384664709A5004395530 @default.
• W4384664709 hasAuthorship W4384664709A5011903525 @default.
• W4384664709 hasAuthorship W4384664709A5026168174 @default.
• W4384664709 hasAuthorship W4384664709A5032417354 @default.
• W4384664709 hasAuthorship W4384664709A5064849327 @default.
• W4384664709 hasAuthorship W4384664709A5066732257 @default.
• W4384664709 hasAuthorship W4384664709A5071884095 @default.
• W4384664709 hasAuthorship W4384664709A5084256816 @default.
• W4384664709 hasConcept C118552586 @default.
• W4384664709 hasConcept C126322002 @default.
• W4384664709 hasConcept C142724271 @default.
• W4384664709 hasConcept C168563851 @default.
• W4384664709 hasConcept C185592680 @default.
• W4384664709 hasConcept C197934379 @default.
• W4384664709 hasConcept C204787440 @default.
• W4384664709 hasConcept C27081682 @default.
• W4384664709 hasConcept C2777847592 @default.
• W4384664709 hasConcept C2778004101 @default.
• W4384664709 hasConcept C2779442783 @default.
• W4384664709 hasConcept C2779541405 @default.
• W4384664709 hasConcept C2781066024 @default.
• W4384664709 hasConcept C48856860 @default.
• W4384664709 hasConcept C535046627 @default.
• W4384664709 hasConcept C55493867 @default.
• W4384664709 hasConcept C71924100 @default.
• W4384664709 hasConceptScore W4384664709C118552586 @default.
• W4384664709 hasConceptScore W4384664709C126322002 @default.
• W4384664709 hasConceptScore W4384664709C142724271 @default.
• W4384664709 hasConceptScore W4384664709C168563851 @default.
• W4384664709 hasConceptScore W4384664709C185592680 @default.
• W4384664709 hasConceptScore W4384664709C197934379 @default.
• W4384664709 hasConceptScore W4384664709C204787440 @default.
• W4384664709 hasConceptScore W4384664709C27081682 @default.
• W4384664709 hasConceptScore W4384664709C2777847592 @default.
• W4384664709 hasConceptScore W4384664709C2778004101 @default.
• W4384664709 hasConceptScore W4384664709C2779442783 @default.
• W4384664709 hasConceptScore W4384664709C2779541405 @default.
• W4384664709 hasConceptScore W4384664709C2781066024 @default.
• W4384664709 hasConceptScore W4384664709C48856860 @default.
• W4384664709 hasConceptScore W4384664709C535046627 @default.
• W4384664709 hasConceptScore W4384664709C55493867 @default.
• W4384664709 hasConceptScore W4384664709C71924100 @default.

• next